Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Marinus Pharmaceuticals
Marinus Pharmaceuticals
(MRNS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ztalmy
Ganaxolone
2023-07-26
2026-2037
Infantile spasms
,
Seizures
,
Epileptic syndromes
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ganaxolone
depression
,
depressive disorder
,
pregnancy complications
,
postpartum depression
,
puerperal disorders
,
mood disorders
,
mental disorders
,
behavioral symptoms
,
partial epilepsies
,
spasm
,
infantile spasms
,
smoking cessation
,
postpartum period
,
fragile x syndrome
,
syndrome
,
post-traumatic stress disorders
,
traumatic stress disorders
,
complex partial epilepsy
,
muscle cramp
,
autistic disorder
,
autism spectrum disorder
,
epilepsy
,
status epilepticus
,
seizures
,
tuberous sclerosis
,
sclerosis
,
drug resistant epilepsy
,
treatment-resistant depressive disorder
,
major depressive disorder
Alfacalcidol
renal cell carcinoma
,
neoplasms
,
uterine cervical neoplasms
,
anemia
,
chronic hepatitis d
,
hepatitis d
,
rheumatoid arthritis
,
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis
Lotamilast
actinic keratosis
,
basal cell carcinoma
,
basal cell neoplasms
Remetinostat
epilepsy
,
seizures
,
complex partial epilepsy
Sepranolone
epilepsy
,
seizures
,
complex partial epilepsy
Usistapide
chronic obstructive pulmonary disease
,
sleep wake disorders
,
alcoholism
,
addictive behavior
,
huntington disease
,
healthy volunteers/patients
,
neoplasms
,
hypoxia
,
anxiety disorders
,
major depressive disorder
,
depressive disorder
,
pain
,
gastroparesis
,
type 2 diabetes mellitus
,
sleep initiation and maintenance disorders
,
obesity
,
dyslipidemias
,
cholestasis
,
pruritus
,
biliary liver cirrhosis
,
diabetes mellitus
,
critical illness
,
intrahepatic cholestasis
,
subarachnoid hemorrhage
,
intracranial vasospasm
,
body weight
,
back pain
,
hypercholesterolemia
,
inflammation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use